Werner Weitschies

22.1k total citations · 1 hit paper
270 papers, 9.2k citations indexed

About

Werner Weitschies is a scholar working on Pharmaceutical Science, Gastroenterology and Biomedical Engineering. According to data from OpenAlex, Werner Weitschies has authored 270 papers receiving a total of 9.2k indexed citations (citations by other indexed papers that have themselves been cited), including 95 papers in Pharmaceutical Science, 67 papers in Gastroenterology and 52 papers in Biomedical Engineering. Recurrent topics in Werner Weitschies's work include Drug Solubulity and Delivery Systems (89 papers), Gastrointestinal motility and disorders (43 papers) and Gastroesophageal reflux and treatments (36 papers). Werner Weitschies is often cited by papers focused on Drug Solubulity and Delivery Systems (89 papers), Gastrointestinal motility and disorders (43 papers) and Gastroesophageal reflux and treatments (36 papers). Werner Weitschies collaborates with scholars based in Germany, Sweden and Switzerland. Werner Weitschies's co-authors include Mirko Koziolek, Werner Siegmund, Grzegorz Garbacz, Michael Grimm, Lutz Trahms, Hubert Mönnikes, Anne Seidlitz, Jens‐Peter Kühn, R. Kötitz and Felix Schneider and has published in prestigious journals such as Nano Letters, Blood and PLoS ONE.

In The Last Decade

Werner Weitschies

266 papers receiving 9.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Investigation of pH and Temperature Profiles in the GI Tract of Fasted Human Subjects Using the Intellicap® System

2014 348 citations Mirko Koziolek, Michael Grimm et al. Journal of Pharmaceutical Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Werner Weitschies Germany	53	3.3k	2.0k	1.4k	1.3k	1.2k	270	9.2k
S.S. Davis United Kingdom	56	4.6k 1.4×	1.5k 0.7×	789 0.6×	2.5k 1.9×	672 0.6×	209	11.1k
Bertil Abrahamsson Sweden	44	3.6k 1.1×	397 0.2×	895 0.7×	1.2k 0.9×	451 0.4×	132	6.3k
Peter Langguth Germany	50	3.3k 1.0×	645 0.3×	315 0.2×	2.2k 1.7×	422 0.4×	271	9.1k
Anette Müllertz Denmark	60	7.3k 2.2×	760 0.4×	450 0.3×	2.1k 1.6×	351 0.3×	274	11.2k
Patrick Augustijns Belgium	73	8.8k 2.7×	1.1k 0.5×	1.0k 0.8×	3.5k 2.7×	1.0k 0.9×	409	18.3k
Juergen Siepmann France	61	9.3k 2.9×	3.2k 1.6×	389 0.3×	2.1k 1.6×	883 0.7×	221	17.2k
Hans Lennernäs Sweden	62	7.6k 2.3×	782 0.4×	781 0.6×	3.2k 2.5×	1.0k 0.8×	269	17.4k
Henderik W. Frijlink Netherlands	59	3.7k 1.1×	1.1k 0.5×	209 0.2×	2.5k 1.9×	372 0.3×	340	12.1k
David Attwood United Kingdom	58	3.0k 0.9×	1.0k 0.5×	358 0.3×	2.9k 2.2×	290 0.2×	342	13.5k
René Holm Denmark	46	4.7k 1.5×	624 0.3×	244 0.2×	1.9k 1.4×	198 0.2×	266	8.3k

Countries citing papers authored by Werner Weitschies

Since Specialization

Citations

This map shows the geographic impact of Werner Weitschies's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Werner Weitschies with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Werner Weitschies more than expected).

Fields of papers citing papers by Werner Weitschies

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Werner Weitschies. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Werner Weitschies. The network helps show where Werner Weitschies may publish in the future.

Co-authorship network of co-authors of Werner Weitschies

This figure shows the co-authorship network connecting the top 25 collaborators of Werner Weitschies. A scholar is included among the top collaborators of Werner Weitschies based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Werner Weitschies. Werner Weitschies is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Page, Susanne, et al.. (2024). Esophageal transit of solid oral dosage forms – impact of different surface materials characterized in vitro and in vivo by MRI in healthy volunteers. European Journal of Pharmaceutical Sciences. 203. 106926–106926. 2 indexed citations

Heß, Florian, et al.. (2024). Understanding the Interaction of Thermal, Rheological, and Mechanical Parameters Critical for the Processability of Polyvinyl Alcohol-Based Systems during Hot Melt Extrusion. Pharmaceutics. 16(4). 472–472. 11 indexed citations

Weitschies, Werner, et al.. (2024). Scalability of API-Loaded Multifilament Yarn Production by Hot-Melt Extrusion and Evaluation of Fiber-Based Dosage Forms. Pharmaceutics. 16(8). 1103–1103. 2 indexed citations

Appel, Bettina, et al.. (2024). Stability of Free and Liposomal Encapsulated RNA on a Mucoadhesive PVA Polymer for Esophageal RNA Drug Targeting Using the EsoCap System. Advanced Therapeutics. 7(8). 2 indexed citations

Weitschies, Werner, et al.. (2023). Influence of Different Diets on the Degradation of Sulfasalazine by Colon Bacteria Determined Using MimiCol3. Pharmaceuticals. 16(8). 1128–1128. 2 indexed citations

Koziolek, Mirko, Patrick Augustijns, Rodrigo Cristofoletti, et al.. (2023). Challenges in Permeability Assessment for Oral Drug Product Development. Pharmaceutics. 15(10). 2397–2397. 12 indexed citations

Berg, Sabine, Michael Grimm, Stefan Hadlich, et al.. (2023). Evaluation of Pharmacobezoar Formation from Suspensions of Spray-Dried Amorphous Solid Dispersions: An MRI Study in Rats. Pharmaceutics. 15(3). 887–887.

Stillhart, Cordula, et al.. (2023). Impact of Tablet Size and Shape on the Swallowability in Older Adults. Pharmaceutics. 15(4). 1042–1042. 16 indexed citations

Page, Susanne, et al.. (2023). Influence of Solid Oral Dosage Form Characteristics on Swallowability, Visual Perception, and Handling in Older Adults. Pharmaceutics. 15(4). 1315–1315. 6 indexed citations

10.

Weitschies, Werner, et al.. (2023). Parameters to consider for successful medication use in older adults - An AGePOP review. European Journal of Pharmaceutical Sciences. 187. 106453–106453. 6 indexed citations

11.

Weitschies, Werner, et al.. (2021). Establishment of a Dissolution Test System for the Biorelevant Characterization of Esophageal Applied Dosage Forms. Journal of Pharmaceutical Sciences. 111(1). 62–68. 3 indexed citations

12.

Koziolek, Mirko, Michael Grimm, Kerstin Schäfer, et al.. (2019). Characterization of the GI transit conditions in Beagle dogs with a telemetric motility capsule. European Journal of Pharmaceutics and Biopharmaceutics. 136. 221–230. 44 indexed citations

13.

Vertzoni, Maria, Patrick Augustijns, Michael Grimm, et al.. (2019). Impact of regional differences along the gastrointestinal tract of healthy adults on oral drug absorption: An UNGAP review. European Journal of Pharmaceutical Sciences. 134. 153–175. 148 indexed citations

14.

Grimm, Michael, Felix Schneider, Marie‐Luise Kromrey, et al.. (2018). Low dose caffeine as a salivary tracer for the determination of gastric water emptying in fed and fasted state: A MRI validation study. European Journal of Pharmaceutics and Biopharmaceutics. 127. 443–452. 28 indexed citations

15.

Seidlitz, Anne, Thomas Reske, Volkmar Senz, et al.. (2015). In vitro study of sirolimus release from a drug-eluting stent: Comparison of the release profiles obtained using different test setups. European Journal of Pharmaceutics and Biopharmaceutics. 93. 328–338. 18 indexed citations

16.

Glöckl, Gunnar, et al.. (2013). Development of a pressure-sensitive glyceryl tristearate capsule filled with a drug-containing hydrogel. International Journal of Pharmaceutics. 461(1-2). 296–300. 17 indexed citations

17.

Garbacz, Grzegorz, et al.. (2012). A novel liquefied gas based oral controlled release drug delivery system for liquid drug formulations. European Journal of Pharmaceutics and Biopharmaceutics. 81(2). 334–338. 5 indexed citations

18.

Venner, Monica, Markus Grube, Eberhard Scheuch, et al.. (2009). Concentration of the macrolide antibiotic tulathromycin in broncho-alveolar cells is influenced by comedication of rifampicin in foals. Naunyn-Schmiedeberg s Archives of Pharmacology. 381(2). 161–169. 36 indexed citations

19.

Krauel, Krystin, B Fürll, Theodore E. Warkentin, et al.. (2008). Heparin‐induced thrombocytopenia – therapeutic concentrations of danaparoid, unlike fondaparinux and direct thrombin inhibitors, inhibit formation of platelet factor 4–heparin complexes. Journal of Thrombosis and Haemostasis. 6(12). 2160–2167. 52 indexed citations

20.

Oswald, Stefan, et al.. (2006). Disposition and Sterol-Lowering Effect of Ezetimibe in Multidrug Resistance-Associated Protein 2-Deficient Rats. Journal of Pharmacology and Experimental Therapeutics. 318(3). 1293–1299. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact